Contact us today for a FREE no-obligation initial consultation

law done differently!

So, What’s Wrong with Invokana?

Aortic Dissection and Antibiotic Use

INVOKANA INJURIES

The new wonder drug Invokana® was controversial from the inception. The drug was approved in March 2013 by a vote of 10 to 5 of the FDA Endocrinologic and Metabolic Drugs Advisory Committee with panel members expressing concern over the risk of kidney damage, heart attack and stroke associated with the drug. In addition, some members of the panel were concerned about the “small volume of data” to support use of the product. Invokana®is manufactured by Janssen Pharmaceuticals a subsidiary of Johnson & Johnson. Invokana is a new drug but it the sponsor Janssen never demonstrated that it is superior to more affordable older drugs such as metformin. Invokana is novel because it works by inhibiting a normal kidney function, which is to return glucose to the blood and discard other undesirable substances.  Instead, the drug increases the amount of undesirable sugar in the urine. In the first year of adverse event reporting data, serious injuries to kidney function were reported this according to Quarterly Weekly.

WHAT ARE THE SIDE EFFECTS AND PROBLEMS WITH INVOKANA?

Unfortunately, there are some serious problems associated with the use of Invokana®. Four serious health issues are:

  • KIDNEY DAMAGE – has been associated with the drug.
  • HEART ATTACK – has been associated with the drug. When the FDA approved Invokana® they required the manufacturer to study the association of between the drug and heart attacks. The study is a 4 year study know as CANVAS which should be concluded in 2017.
  • KETOACIDOSIS – has been diagnosed with the drug and can be life threatening. It occurs when ketones increase in a person’s blood or urine. The Food & Drug Administration (FDA) has issued warnings about this condition in May, 2015 and December, 2015
  • AMPUTATIONS–On May 18, 2016, the FDA issued a safety announcement alerting the public and physicians about clinical trial results that found an increased risk of leg and foot amputations, mostly affecting toes, with the diabetic medicine Invokana® and Invokamet®. The amputations occurred about twice as often in patients treated with Invokana compared to patients treated with placebo.

QUESTIONS

The James Esparza Law Group is evaluating Invokana injury cases for a select group of clients. If you have questions and would like to discuss your situation, please contact us.  Click contact or call us toll free at 1-800.745.4050. We are here to help you. 

 

 

Top